Analyst Price Target is $15.00
▲ +74.42% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Hims & Hers Health in the last 3 months. The average price target is $15.00, with a high forecast of $20.00 and a low forecast of $12.00. The average price target represents a 74.42% upside from the last price of $8.60.
Current Consensus is
The current consensus among 8 polled investment analysts is to hold stock in Hims & Hers Health. This rating has held steady since March 2021, when it changed from a Buy consensus rating.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.